Risk factors for immune‐related adverse events from anti‐PD ‐1 or anti‐ PD‐L1 treatment in an Asian cohort of nonsmall cell lung cancer patients-Reference-Cited by-同舟云学术

Risk factors for immune‐related adverse events from anti‐PD ‐1 or anti‐ PD‐L1 treatment in an Asian cohort of nonsmall cell lung cancer patients

Author:

Huang Yiqing¹^ORCID,Soon Yu Yang²,Aminkeng Folefac³,Tay Sen Hee⁴,Ang Yvonne¹,Kee Adrian C. L.⁵,Goh Boon Cher¹,Wong Alvin S. C.¹,Soo Ross A.¹

Affiliation:

1. Department of Haematology‐Oncology National University Cancer Institute, Singapore Singapore

2. Department of Radiation Oncology National University Cancer Institute, Singapore Singapore

3. Department of Pharmacology, Yong Loo Lin School of Medicine National University of Singapore Singapore

4. Department of Medicine, Rheumatology Division National University Hospital Singapore

5. Department of Medicine, Respiratory Division National University Hospital Singapore

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

Reference43 articles.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献